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Transposition in Painful end-
neuromas of superficial radial 
nerve: Preliminary results
Simon Zimmermann†, Richard M. Fakin*†, Pietro Giovanoli and Maurizio Calcagni
Division of Plastic and Hand Surgery, University Hospital Zurich, Zurich, Switzerland
introduction: The management of painful end-neuromas of the superficial branch of 
the radial nerve (SBRN) remains challenging due to high levels of pain relapse. The novel 
technique of stromal vascular fraction (SVF)-enriched fat grafting showed continuous 
pain relief, although failed to prove statistically significant. Besides acting as a mecha-
nical barrier, SVF-enriched fat grafting might also affect the cellular level. The aim of this 
study was to compare clinical outcomes of SVF to the widely popular intramuscular 
transposition technique.
Patients and methods: In this cohort study, 10 consecutive patients treated for painful 
end-neuromas of the SBRN between 2010 and 2013 were analyzed retrospectively. 
Microsurgical resection of end-neuromas was performed in all patients. Five patients 
were treated with subsequent intramuscular transposition into the brachioradialis muscle 
and five patients received SVF-enriched fat grafting. Five different pain modalities and 
various predictors were compared pre- and up to 36 months post-operatively.
results: In the transposition group, sustained pain reduction was not observed after an 
initial significant reduction 2 months’ post-surgery, resulting in pain relapse at 36 months 
and comparable to the preoperative assessment. In the graft group, some degree of 
pain reduction was observed at 2 months after the surgery and proved to be constant 
in the long-term outcome, although not statistically significant compared to preoperative 
levels.
conclusion: Both SVF-enriched fat grafting and intramuscular transposition failed to 
prove statistical significant pain reduction in treating symptomatic neuromas of periph-
eral nerves.
Keywords: symptomatic neuroma, pain, stromal vascular fraction, fat grafting, sVF
inTrODUcTiOn
The management of painful end-neuromas of the superficial branch of the radial nerve (SBRN) 
remains difficult with multitude of existing proposed surgical treatments. Principally, neuroma 
excision and/or repositioning of the nerve stump into neighboring muscles (1, 2), bone (3), and 
veins (4) were proposed. Further attempts, such as stripping off the whole branch of the nerve (5), 
FigUre 1 | After neuroma removal, the remaining proximal nerve stump of 
the superficial branch of the radial nerve was prepared for transposition into 
the brachioradialis.
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centro-centralization (6), or coverage with vascularized flaps 
(7) have been attempted. All of these techniques share the main 
concept of providing a mechanic barrier during nerve regenera-
tion in order to reduce the messy axonal sprouting of terminal 
neuromas (8).
Recently, our group reported the novel treatment for symp-
tomatic neuromas of the SBRN by stromal vascular fraction 
(SVF)-enriched fat grafting (9). SVF is a heterogeneous cell popu-
lation, including concentrated amount of adipose-derived stem 
cells (ADSC) (10). SVF-enriched fat grafting might also affect 
the cellular level by a variety of biological mechanisms, includ-
ing angiogenesis, differentiation potential, immunomo dulatory 
properties, and secretion of extracellular matrix (11). The SVF is 
added to the fat graft in order to decrease the resorption rate and 
boost the regenerative potential of fat graft. Thus, the mechanical 
barrier provided by the fat graft might be maintained continu-
ously during nerve regeneration, and SVF-enriched fat grafting 
might reduce the disorganized sprouting of terminal neuromas 
and subsequent nerve adherences.
Our small collective of five patients was the largest ever pub-
lished series reporting SVF-enriched fat grafting in a single nerve 
population, although failed to show statistically significant pain 
reduction. However, a trend in continuous pain reduction could 
be demonstrated (9).
Indeed, none of described treatments resulted in superior 
outcome yet, and hence failed to establish a therapy consensus 
considering high rates of pain relapse (12). Furthermore, various 
prognostic factors for inferior pain relief following the surgery 
were described previously, including duration of pain for over 
48 months, employment status, complex regional pain syndrome 
(CRPS) II symptoms, and smoking habits (12).
This cohort study compares a long-term outcome of SVF-
enriched fat grafting as a novel surgical option for symptomatic 
end-neuromata of SBRN to the still frequently assessed alterna-
tive of intramuscular transposition of the nerve stump.
PaTienTs anD MeThODs
This study was carried out in accordance with the recommenda-
tions of the University of Zurich Ethics Committee with written 
informed consent from all subjects. All subjects gave written 
informed consent in accordance with the Declaration of Helsinki. 
The protocol was approved by the University of Zurich Ethics 
Committee (BASEC-Nr. Req-2016-00655).
All patients operated on painful end-neuromata of the SBRN 
between 2010 and 2013 in our institution were analyzed retro-
spectively. From 2010 to 2012, five consecutive patients were 
treated with neuroma excision and intramuscular transposition 
into the brachioradialis muscle (the transposition group) and 
from 2012 to 2013 five consecutive patients received SVF-
enriched fat grafting (the graft group). All the surgeries were 
performed by the same surgeon. Duration of pain, employment 
status, previously diagnosed CRPS II symptoms, and smoking 
habits of all patients were documented prior to the surgery. The 
data of both groups were statistically analyzed and compared. 
Symptoms of CRPS II were often primarily diagnosed in periph-
eral hospitals and not confirmed by specialists in our institution.
In order to confirm the diagnosis, all relevant nerve blocks 
were performed proximally to the neuroma in the middle third 
of the forearm in order to exclude pain from overlapping nerves, 
such as the lateral antebrachial cutaneous nerve (LACN) (13), 
posterior interosseous nerve (PIN), and a dorsal branch of ulnar 
nerve. In sequential order, all lidocaine blocks were completed 
by the same neurologist under sonographic control. The block 
for the SBRN was performed approximately 12–15 cm proximal 
to the lesion at the mid forearm. The LACN was blocked 10 cm 
distal to the biceps tendon on the forearm. Finally, the block 
for posterior interosseous nerve and for a dorsal branch of 
ulnar nerve was applied. Preoperative CRPS II and centraliza-
tion of the pain were excluded analogously. Surgery was only 
performed in patients with considerable pain reduction [at least 
five VAS points on the Visual Analog Scale (VAS) for pain]. 
Pain modalities were evaluated as proposed by Elliot et  al. 
(14). Spontaneous pain, spikes, hyperesthesia, tap pain, and 
motion pain affecting the skin over the neuroma were rated by 
our patients from 0 to 3 for each pain modality [none (0), mild 
(1), moderate (2), and severe pain (3)]. The clinical evaluation of 
pain was performed prior to surgery and during the follow-up 
at 2, 6, 12, and 36 months. Pain modalities were postoperatively 
evaluated both over the original site of painful neuroma, and 
over either the site of intramuscular transposition or of SVF-
enriched fat grafting. In patients with persistent pain following 
the surgery, the diagnostic nerve blocks were repeated and the 
results documented.
surgical Procedure
Transposition Group
Under the microscope, the painful neuroma was resected and 
dissection of the proximal nerve stump was performed until the 
sufficient length was obtained for tension-free relocation into the 
brachioradialis muscle (Figure  1). A recipient site was created 
by a gentle and atraumatic division of the muscle fibers. The 
nerve stump was translocated 2  cm deep into the muscle. The 
nerve stump was consequently fixated with simple stitches with 
polypropylene 9–0 from the epineurium to the epimysium.
FigUre 3 | Communicating syringes were used to mix 5 ml of the 
concentrated stromal vascular fraction (SVF) with 2 ml of the sedimented lipid 
fraction in order to get the SVF-enriched fat graft.
FigUre 2 | As application tool, four blunt cannulas were transcutaneously 
inserted and perineurally arranged around the nerve stump.
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SVF-Enriched Fat Graft Group
A minimum of 220 ml of lipoaspirate was harvested through 
tumescent liposuction. In conformity with the manufacturers 
guidelines, the lipoaspirate was transferred into the Celution® 
800/CRS System and processed by one ampule of Celase® 
processing enzyme reagent (Cytori Therapeutics, San Diego, 
CA, USA) (15). Meanwhile, the neuroma was excised under 
the microscope and subsequently neurolysis was performed. 
The nerve stump was dissected for at least 3  cm proximally 
to the wrist. Four small 1 mm transcutaneous incisions were 
arranged around the principal approach and blunt cannulas 
were placed perineurally to the nerve and secured in place by 
adhesive dressing (Figure  2). The wound was tightly closed 
with the blunt cannulas in  situ. Then 5  ml of the processed 
SVF and 2 ml of the aspirated and sedimented lipid fraction 
were shuffled by communicating syringes (Figure 3). Finally, 
the SVF-enriched fat graft was injected perifocal to the nerve 
stump via the cannulas. The cannulas were removed and the 
incisions sutured.
statistical analysis
The data were analyzed using the IBM Statistical Package for Social 
Sciences, version 22 (SPSS, Chicago, IL, USA) and presented as 
mean ±  SDs. The Kolmogorov–Smirnov test was employed to 
verify the nonparametric nature of the study population and 
confirmed a nonexistent empirical distribution. Based on the 
nonparametric nature of the study population, the Wilcoxon’s 
test for related samples was applied to compare preoperative and 
postoperative results. The Mann–Whitney U test was used to 
verify statistical significance between the respective pain scores 
of each group. Statistical significance was considered at p-value 
less than 0.05.
resUlTs
The baseline characteristics of the study population are pre-
sented in Table  1. Eight male and two female patients with 
adequate pain reduction following the nerve blockade were 
included with a mean age of 41.5 ± 13.2 years. In eight patients, 
the neuromas of the SBRN manifested due to a previous trauma 
and in two patients due to an iatrogenic injury during ortho-
pedic interventions. The mean duration of preoperative pain 
was 45.35 ± 46.98 months, ranging from 5 months to 12 years. 
Six patients had symptoms of CRPS II in their past medical 
history, which was documented in a peripheral hospital and 
could neither be confirmed by the surgeon nor by the neurolo-
gist practicing in our institution. Four patients were employed 
and six were unemployed. Nine patients smoked at the time 
of the surgical management (mean duration: 13.9 ± 10.7 pack 
years).
The standard postoperative immobilization period amounted 
4  weeks in the transposition group and 10  days in the SVF-
enriched fat grafting group.
The comparison of pre- and postoperative pain scores of the 
two groups are listed in Tables 2–6 for each pain modality.
Statistically significant pain reduction could be shown in 
the transposition group 2  months after the surgery for the 
majority of pain modalities and on overall pain assessment. 
Afterward, subsequent increase of pain was detected and 
failed to maintain statistical significance from 6 months’ post-
surgery onward. An overall pain reduction from 36  months 
after the surgery was assessed as follows: spontaneous pain 
from 2.2 ± 0.84 to 1.4 ± 1.34 (p = 0.157), hyperesthesia from 
2.8 ± 0.45 to 2.2 ± 0.84 (p = 0.180), tap pain from 3 ± 0.0 to 
2.8 ±  0.45 (p =  0.317), and motion pain from 2.8 ±  0.45 to 
1.6 ± 1.52 (p = 0.194). Spikes were assessed 36 months after 
the surgery at the same level as before the surgery (p =  1.0) 
(Figure 4).
The graft group showed a relevant reduction in all pain 
modalities 2  months after the surgery, although the difference 
did not reach statistical significance. However, pain reduction 
appeared to be maintained during 36 months after the surgery. 
Spontaneous pain could be reduced from 1.6 ± 0.55 to 1.2 ± 1.1 
(p =  0.414), spikes from 2.2 ±  1.3 to 1.4 ±  1.34 (p =  0.180), 
hyperesthesia from 1.6 ± 1.14 to 1.2 ± 1.64 (p = 0.713), tap pain 
from 2.8 ± 0.45 to 1.8 ± 1.3 (p = 0.197), and motion pain from 
2.8 ± 0.45 to 1.4 ± 1.34 (p = 0.066) (Figure 5).
FigUre 5 | The assessment of pain modalities before and after stromal 
vascular fraction-enriched fat grafting.
FigUre 4 | The assessment of pain modalities before and after 
intramuscular transposition.
Table 6 | Mean motion pain ± SDs (p-value).
Transposition group graft group
Preoperative score 2.8 ± 0.45 2.8 ± 0.45
2 monthsa 0.2 ± 0.45 (0.034) 1.4 ± 1.52 (0.102)
6 monthsa 2 ± 0.71 (0.102) 1.2 ± 1.64 (0.102)
12 monthsa 2.4 ± 0.55 (0.157) 1.6 ± 1.52 (0.109)
36 monthsa 1.6 ± 1.52 (0.194) 1.4 ± 1.34 (0.066)
aMonths after the surgery.
p-Value shows the difference between the pre- and postoperative scores.
Table 5 | Mean tap pain ± SDs (p-value).
Transposition group graft group
Preoperative score 3 ± 0.0 2.8 ± 0.45
2 monthsa 0.8 ± 0.84 (0.041) 1.6 ± 0.89 (0.083)
6 monthsa 2.6 ± 0.55 (0.157) 1.6 ± 1.52 (0.157)
12 monthsa 3 ± 0.0 (1.0) 1.8 ± 1.3 (0.180)
36 monthsa 2.8 ± 0.45 (0.317) 1.8 ± 1.3 (0.197)
aMonths after the surgery.
p-Value shows the difference between the pre- and postoperative scores.
Table 4 | Mean hyperaesthesia ± SDs (p-value).
Transposition group graft group
Preoperative score 2.8 ± 0.45 1.6 ± 1.14
2 monthsa 1.4 ± 0.89 (0.038) 1.2 ± 1.64 (0.713)
6 monthsa 1.8 ± 1.3 (0.102) 1.4 ± 1.52 (0.713)
12 monthsa 2.2 ± 1.1 (0.180) 1.4 ± 1.52 (0.713)
36 monthsa 2.2 ± 0.84 (0.180) 1.2 ± 1.64 (0.713)
aMonths after the surgery.
p-Value shows the difference between the pre- and postoperative scores.
Table 3 | Mean spikes ± SDs (p-value).
Transposition group graft group
Preoperative score 2.6 ± 0.55 2.2 ± 1.3
2 monthsa 1 ± 0.71 (0.038) 1.4 ± 1.52 (0.285)
6 monthsa 2.2 ± 0.84 (0.157) 1.8 ± 1.64 (0.655)
12 monthsa 2.4 ± 0.89 (0.317) 1.8 ± 1.64 (0.655)
36 monthsa 2.6 ± 0.55 (1.0) 1.4 ± 1.34 (0.180)
aMonths after the surgery.
p-Value shows the difference between the pre- and postoperative scores.
Table 2 | Mean spontaneous pain ± SDs (p-value).
Transposition group graft group
Preoperative score 2.2 ± 0.84 1.6 ± 0.55
2 monthsa 0.4 ± 0.55 (0.066) 0.8 ± 0.84 (0.102)
6 monthsa 1.8 ± 0.84 (0.157) 1.6 ± 1.52 (1.0)
12 monthsa 2 ± 0.71 (0.317) 1.6 ± 1.52 (1.0)
36 monthsa 1.4 ± 1.34 (0.157) 1.2 ± 1.1 (0.414)
aMonths after the surgery.
p-Value shows the difference between the pre- and postoperative scores.
Table 1 | Baseline characteristics.
Overall Transposition 
group
graft  
group
Sex—male
—female
8
2
3
2
5
0
Injury—trauma
—iatrogenic
8
2
4
1
4
1
Mean age (in years) 41.5 ± 13.2 39.2 ± 8.79 49.8 ± 16.59
Mean duration of  
preoperative pain  
(in months)
45.35 ± 46.98 23.2 ± 16.48 67.5 ± 58.88
Complex regional  
pain syndrome II 
symptoms—Yesa
—No
6
4
5
0
1
4
Employment  
status—employed
—unemployed
4
6
2
3
2
3
Smoking—Yes  
(mean pack years)
—No
9 (13.9 ± 10.7)
1
5 (8.55 ± 6.31)
0
4 (19.25 ± 9.43)
1
aCRPS II was documented in a peripheral hospital and could neither be confirmed by 
the surgeon nor by the neurologist practicing in our institution.
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The overall assessment of pain modalities in each group is 
shown and compared in Figure 6. Comparing the mean pre- and 
postoperative pain scores after 2, 6, 12, and 36 months of the two 
groups, no statistical significance was detected.
FigUre 6 | Comparison of overall assessment of pain modalities for each 
group.
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and a significantly higher number and diameter of myelinated 
fibers in a test series on sciatic nerves in rats (24). Interestingly, 
the application of undifferentiated ADSCs in an artificial nerve 
conduit in a rat sciatic nerve model, resulted in a detection of 
only a small amount of viable ADSCs 2 weeks after the trans-
plantation (25). Hence, rather than playing a dominate role 
in direct neuronal differentiation, ADSCs might contribute 
to nerve regeneration through initially boosting neurotrophic 
factors, such as BDNF, NGF, and GDNF and their interactivity 
with SC (25, 26). Concluding, SVF-enriched fat grafting might 
present a relevant component in nerve regeneration, particu-
larly in providing sufficient myelinated fibers for an organized 
nerve outgrowth, and potential prevention of the messy axonal 
sprouting of terminal neuromas (9).
In addition, SVF-enriched fat grafting might provide biologic 
mechanisms, such as immunomodulation and secretion of 
extracellular matrix as local inflammation and following immune 
response are crucial parts in the process of nerve regeneration 
(11). Immunomodulation is observed by hematopoietic cells, 
such as macrophages of the M2 phenotype or T helper cells and 
natural killer cells in the SVF which provide anti-inflammatory 
function by secreting of numerous cytokines (27). Furthermore, 
the cellular signaling is influenced, though a decrease of pro-
inflammatory cytokines like TNF-α and IL-6 (28). Cellular 
signaling and migration is influenced via the expression of matrix 
components by fibroblasts in the SVF (11).
In our results, some degree of improvement was manifested 
following SVF-enriched fat grafting, though pain reduction did 
not prove to be statistically significant. However, pain reduction 
was shown continuous at a steady state from 2 months postop-
eratively onward, with no pain relapse up to at least 36 months. 
Consequently, this favorable trend might be associated both with 
a greater long-term residual volume of the fat graft due and the 
proposed biologic mechanisms attributable to the SVF (11, 19). 
Concluding, our preliminary results in pain reduction are in 
accordance with other results published in the field of autologous 
fat injections in painful neuromas (29).
The processed SVF should be added to the fat graft in the 
proposed optimum of 10,000 cells per 200 µl adipose tissue as 
higher amounts of SVF significantly increase the resorption 
rate (30). Moreover, the regenerative potential of the fat graft is 
decreased with higher fractions.
Despite centralization of pain and preoperative CRPS II 
were excluded by preoperative nerve blocks, the chance of suc-
cess in pain reduction is a priori inferior after long periods of 
unsuccessful pain therapy. Furthermore, the anatomical overlap 
between SBRN and LACN might be an underestimated factor 
for decreased pain relief. Although verifying preoperative nerve 
blocking was performed to confirm the diagnosis, postoperative 
disorganized outgrowth of the LACN in the denervated com-
mon cutaneous innervation area cannot be excluded. In patients 
with persistent pain post-surgery, the diagnostic nerve blocks, 
especially of the LACN, were repeated. If considerable pain 
reduction could be shown, surgical follow-up intervention was 
offered to the patients. Resection of the LACN was secondarily 
performed in one patient in the transposition group follow-
ing an 18  months regime of non-operative pain management. 
DiscUssiOn
The aim of this cohort study was to compare the long-term 
outcome of SVF-enriched fat grafting to the widely popular 
intramuscular transposition in the treatment of painful end-
neuromas of the SBRN. Our data suggest no significant pain 
reduction by SVF-enriched fat grafting compared to intramus-
cular transposition in neuromal pain over an observation period 
of 3  years. However, SVF-enriched fat grafting shall provide 
a beneficial action on cellular level by a variety of biological 
mechanisms, including angiogenesis, differentiation potential, 
immunomodulatory properties, and secretion of extracellular 
matrix (11).
Neuromas of the SBRN are associated with a surgical success 
rate of only 33% (12). The surgical procedure is often performed 
after a long regime of non-operative pain management. Vaienti 
et  al. reported a series of promising results of perineurial fat 
grafting (PFG) without the SVF in eight patients suffering of 
painful neuromas of the upper limb (16, 17). However, pain 
reduction failed to show a statistical significance from 6 months 
postoperatively onward with pain relapse 12  months after the 
PFG (16, 17).
In previous trials, ADSCs-enriched adipose grafts showed 
a considerably reduced absorption rate in comparison to 
non-enriched fat grafts (18). ADSC as part of the SVF acti-
vate angiogenesis and the expression of growth factors, such 
as VEGF and bFGF on cellular level (19). Thus, acting as a 
mechanic barrier, the SVF-enriched fat graft might be sus-
tained continuously, particularly in the vulnerable period of 
nerve regeneration.
Besides its impact as a mechanical layer, the therapeutic 
effect of SVF-enriched fat grafting is believed to be based on 
a cellular level. And therefore, proving a potential answer to 
the proposed partial chemical component in neuromal pain 
(20, 21). An intact perineurium is believed to be of utmost 
importance in neuromal formation. Undamaged perineurium 
presents an impermeable membrane in nerve regeneration and 
prevents disorganized terminal sprouting of nerve fibers (22). 
During axonal outgrowth in nerve regeneration, Schwann cells 
play a dominant role (23). SVF-enriched nerve conduits were 
shown to be responsible for an accelerated axon regeneration 
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This additional surgical intervention, however, resulted in only 
minor pain improvement. Two patients in the graft group with 
minor or no improvement of pain received repeated diagnostic 
nerve blocks, with a special attribute to the LACN. Nonetheless, 
considerable pain reduction could not be achieved. Patients with 
persisting pain post-surgery were continuously followed in our 
specialized pain unit.
Prognostic risk factors for inferior pain relief were described 
previously (12). Most of our patients were unemployed with 
current smoking habits at the time of the surgery and had docu-
mented CRPS II symptoms in their past medical history. The mean 
duration of preoperative pain was 67.5 months in the graft group, 
representing a further unfavorable predictor as compared to the 
transposition group. Regardless of which operative technique 
was assessed, insufficient pain reduction was observed in patients 
with at least two out of four proposed predictors. Consequently, 
our results can confirm the negative influence of these proposed 
risk factors.
Both surgical techniques aim to protect the nerve stump 
against mechanical irritation, either by muscle or fat graft, in 
order to prevent persistent and disorganized axonal outgrowth. 
Pain reduction in SVF-enriched fat grafting failed to show a 
statistical significance as compared to the muscular transposition 
approach.
In the transposition group, sustained pain relief was not obser-
ved after an initial significant symptom reduction at 2  months 
after the operation, resulting in pain 36  months’ post-surgery 
comparable to the preoperative status. Notably, this pattern was 
not observed in the graft group. In contrast, the long-term out-
come and particularly pain relief appeared to be sustained from 
2 months postoperatively onward.
The initial significant pain reduction achieved in the transpo-
sition group is likely due to neuroma resection itself. However, 
with subsequent continuous axonal outgrowth, the muscle does 
not appear to offer the desired protective effect during the nerve 
regeneration. In contrast, we speculate that the continuous 
pain reduction in the graft group is probably due to persistent 
biological effects of the SVF indeed.
Besides, SVF-enriched fat grafting does not require the 
surgical intervention of the brachioradialis muscle and offers a 
much shorter immobilization period of the wrist. This needs to 
be taken into consideration when evaluating the more expensive 
and time-consuming operative intervention by SVF-enriched 
fat grafting.
This cohort study is limited both due to the retrospective 
design and small number of patients. Additionally, a slight 
difference was noticed in the preoperative pain score between 
the fat grafting group and transposition group. As neuromas of 
the SBRN are a rare condition and their surgical approach even 
less common, all patients operated on neuromas of the SBRN 
between 2012 and 2013 either by fat grafting or intramuscular 
transposition were included, independently of their preoperative 
pain score. Hence, the difference in pain reduction within both 
groups was compared instead of pre- and postoperative pain 
scores.
Although the present series is the largest to investigate the 
outcome of SVF-enriched fat grafting on a single nerve popula-
tion up to date, future randomized studies with more patients 
are necessary in order to validate the assessment of this novel 
treatment (21).
cOnclUsiOn
Stromal vascular fraction-enriched fat grafting is a novel approach 
for the complex treatment of painful end-neuromas of the SBRN. 
In this study, however, both SVF-enriched fat grafting and intra-
muscular transposition failed to prove statistical significant pain 
reduction in treating of symptomatic neuromas of peripheral 
nerves. As SVF-enriched fat grafting yields promising results in 
laboratory setting, clinical investigations of the exact mechanisms 
of action, and subsequent validation in larger clinical trials are 
needed.
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